Redirect Notice
 The previous page is sending you to http://www.marketwatch.com/story/biogen-idec-and-isis-pharmaceuticals-announce-global-collaboration-for-antisense-program-targeting-spinal-muscular-atrophy-2012-01-04.

 If you do not want to visit that page, you can return to the previous page.